The return of appetite is not evidence of metabolic damage but rather the removal of pharmacological appetite suppression
Clinical studies have demonstrated its effectiveness for these purposes but have also documented vision changes that can occur in some patients, including blurred vision, worsening diabetic retinopathy and macular complications
The field is not converging on a successor
All three medications achieve their effect primarily through appetite suppression
S., Christensen, S., Gianos, E., Gulati, M., Gupta, A., Horn, D., Kane, R
Week-by-Week Progress with Semaglutide for Weight Loss Week 1-4: Starting Low At the beginning of treatment, semaglutide is introduced at a 0.25 mg dose